| pubmed-article:9649951 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9649951 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9649951 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:9649951 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:9649951 | lifeskim:mentions | umls-concept:C0038766 | lld:lifeskim |
| pubmed-article:9649951 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:9649951 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9649951 | pubmed:dateCreated | 1998-9-8 | lld:pubmed |
| pubmed-article:9649951 | pubmed:abstractText | To determine the effect(s) on glucose control, insulin dose, and circulating insulin levels of the addition of a sulfonylurea (glipizide) to the treatment regimen of patients with insulin-requiring type 2 diabetes mellitus. | lld:pubmed |
| pubmed-article:9649951 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9649951 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9649951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9649951 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9649951 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9649951 | pubmed:issn | 0168-8227 | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:FeinglosM NMN | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:EnglishJ SJS | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:McNeillD BDB | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:LobaughBB | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:ThackerC RCR | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:DeAtkineD DDD | lld:pubmed |
| pubmed-article:9649951 | pubmed:author | pubmed-author:BurseyD LDL | lld:pubmed |
| pubmed-article:9649951 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9649951 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:9649951 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9649951 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9649951 | pubmed:pagination | 193-9 | lld:pubmed |
| pubmed-article:9649951 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:meshHeading | pubmed-meshheading:9649951-... | lld:pubmed |
| pubmed-article:9649951 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9649951 | pubmed:articleTitle | Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. | lld:pubmed |
| pubmed-article:9649951 | pubmed:affiliation | Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. | lld:pubmed |
| pubmed-article:9649951 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9649951 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9649951 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9649951 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9649951 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
